Monitoring Early Breast Cancer Response to Neoadjuvant Therapy Using H‐Scan Ultrasound Imaging: Preliminary Preclinical Results

Abstract

Preliminary preclinical results suggest that H-scan ultrasound imaging is a new and promising tissue characterization modality. H-scan ultrasound imaging may provide prognostic value when monitoring early tumor response to neoadjuvant treatment.